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Objective: Brucellosis is endemic in Saudi Arabia. This report summarizes the epidemiology of brucellosis in 
children. 
Method: A retrospective review was made of medical records of all patients admitted to King Fahad National Guard 
Hospital with brucellosis during the period from 1984 to 1995. 
Results: Children 112 years constituted 115/545 (21%) of the total brucellosis admissions. The mean age was 5.8 
years and 64% of the patients were males. Consumption of unpasteurized milk (often from camel) was the main 
source of infection. In 70% the clinical picture was dominated by arthritis, 20% of patients presented with a non- 
specific febrile illness without localizing signs, and 10% had a febrile illness with uncommon presentations. Brucella 
serology was most helpful in making an early diagnosis. Initial titers of >1:640 were found in 90% of the cases. 
Bacteremia was observed in 45% and of the isolates speciated, 96% were Brucella melitensis. No increase in resistance 
to commonly used antimicrobials was noted during the 12-year study period. A combination of rifampin plus co- 
trimoxazole with or without streptomycin was used in two thirds of the patients. The overall rate of relapse was 9% 
and one patient died from neurobrucellosis. 
Conclusion: Brucellosis presents in various ways and should be included in the differential diagnosis of arthritis in 
endemic countries. Prevention should rely on education including on boiling raw milk. 
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In Saudi Arabia, brucellosis is an endemic zoonotic 
disease.lA Although it is believed that children are 
uncommonly involved, a number of reports from 
endemic areas showed a higher percentage of children 
involved (20-30% of affected patients).5,6 Clinical mani- 
festations of childhood brucellosis are varied ranging 
from minimal symptoms to extreme morbidity and 
occasional fatality. Asymptomatic infections are also not 
uncommon. 
The fact that brucellosis is endemic in the Kingdom 
became clearer in the early 1980s. Several reasons have 
been considered but the most prominent of them is the 
increase in the importation of animals from areas where 
brucellosis is endemic, especially some African 
countries. Consumption of raw milk and to a lesser 
extent contact with infected animals or their products 
are the main routes of infection. The consumption of 
fresh, unpasteurized milk from camels is a traditional 
practice, and people believe that boiling removes the 
goodness from the milk. 
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This review was made to clarify the epidemiology, 
clinical features, and response to therapy in selected 
children in Riyadh City, the capital of Saudi Arabia. 
MATERIALS AND METHODS 
King Fahad National Guard Hospital (KFNGH) serves 
a large population of Saudi National Guard Soldiers 
and their extended families. Many of these individuals 
live traditional life styles in close association with live- 
stock such as sheep, camels, and goats. The consumption 
of raw milk from animals, in which the incidence of 
brucellosis is high, is a cultural norm. 
A retrospective review was made of all patients 
admitted to KFNGH with brucellosis from 1984 to 1995. 
Patients included were those ~12 years of age and who 
had clinical features suggestive of brucellosis and serum 
agglutination titre (SAT) for brucella of >1:160, and/or 
positive blood or body fluid culture for Brucella spp. 
From 1983 to 1985, blood and other sterile body fluids 
were cultured in tryptic soy broth and Thiol broth 
bottles (Difco Laboratories, East Molesey, United 
Kingdom). If growth developed (or routinely if no 
growth was observed), subculturing was done onto 
chocolate agar, blood agar, and enriched modified blood 
agar for anaerobes. For initial cultures, CO2 was used, 
but further testing did not require COZ. If brucellosis 
was indicated in the differential diagnosis, the culture 
was held for three weeks before being discarded; routine 
subculturing was done at weeks two and three. In 1986, 
the laboratory began to use the BACTEC 660 system 
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Table 1. Brucellosis in children - 115 cases: presenting 
symptoms and physical findings 
Symptoms and physical findings No. of patients I%) 
Symptoms 
fever 
arthralgia/arthritis 
chills 
malaise 
excessive sweating 
headache 
miscellaneous 
Physical findings 
fever 
arthritis 
hepatomegaly 
splenomegaly 
neck stiffness 
miscellaneous* 
101 (87.8) 
84 (73.0) 
21 (18.2) 
21 (18.2) 
10 (8.6) 
8 (7.0) 
7 (6.0) 
105 (91.3) 
82 (71.3) 
15 (13.0) 
14 (12.1) 
3 (2.6) 
8 (7.0) 
Skin rash=2; cervical nodes=2; drowsiness=2; periorbital swelling=l; 
ataxia=l. 
Table 2. Brucellosis in children - 115 cases: 
febrile illness with uncommon findings 
Uncommon findings 
Neurobrucellosis 
Thrombocytopenia 
Acute abdomen/diarrhea 
Pneumonia 
Myocarditis 
Nephritis 
Hepatitis 
Myelodysplastic syndrome 
Total 
No. 
12 
Table 3. Brucellosis in children - 115 cases: routine laboratory 
findings 
Laboratory test No. tested 
Percent 
abnormal 
Leukopenia (< 5000 x lob/L) 115 9.5 
Leukocytosis (>lO,OOO x lob/L) 115 22.6 
Monocytosis 115 22.6 
ESR (> 25 mmlhr) 88 73.8 
Anemia 115 25.0 
LFT (SGPT, bilirubin) 49 18.3 
Table 4. Brucellosis in children - 115 cases: serology (initial 
titer) 
Positive culture 
Titer No. of patients Blood Other sites 
Not done 2 1 1* 
Titer 5 1:80 1 1 0 
Titer <I:160 0 0 0 
Titer 2 I:320 112 38 3 
Total 115 40 4 
*Positive CSF and peritoneal fluid (VP shunt infection). 
(Becton-Dickinson, Towson, Maryland) for initial blood 
cultures with subculture onto enriched media and 
speciation by biochemical methods: COz requirement, 
urease activity, and growth on basic fuchsin and thionin 
dyes. In 1995, the BACTEC 660 system was replaced by 
the BACTEC 9240 system for initial blood cultures with 
subculturing onto chocolate blood agar at 37°C in COz. 
Antimicrobial susceptibility testing was performed by 
broth dilution.7,8 
The species of brucella was determined by standard 
biochemical methods. The species of some isolates 
were not discovered because of shortage of reagents 
from time to time. Brucella SAT was performed using a 
microtiter agglutination procedure with B. abortus and 
B. melitensis antigens (stained B. abortus SS14 and B. 
melitensis SS15 suspensions, containing approximately 
1010 organisms/ml; Wellcome Diagnostics, Dartford, 
England). Cook microtiter plates were used to receive 
specimens and controls. Each serum was diluted from 
1:80 to 1:20,480, which overcomes the prozone phenom- 
enon. Each batch of tests included a positive 1:1280 and 
a negative saline control.9 
RESULTS 
One hundred and fifteen children ranging in age 
between 6 months and 12 years were included. This 
represents l-8/1000 of children discharged through 1995. 
The highest incidence was noticed in 1987 and 1988. 
Gender distribution showed male predominance (74 
[64.3%] patients were males). Eighty five percent of 
patients had history of raw milk ingestion and 47% had 
a family history of brucellosis. The presenting symptoms 
and clinical signs are shown in Table 1. Most (76%) of 
the patients presented within the first two weeks of their 
illness. The most common presenting symptoms included 
fever in 87.8%, followed by arthralgia/arthritis in 73% of 
patients. Physical findings on presentation included 
fever in 91.3%, arthritis 71.3%, and hepatomegaly and 
splenomegaly in 13% and 12% respectively. 
Most patients (76%) presented with acute symptoms 
of no longer than 2 weeks duration, while 10 patients 
(8.7%) had a chronic presentation with symptoms 
before hospitalization of more than 6 weeks; 18 (15.6%) 
had subacute presentation >2 weeks to <6 weeks.There 
were three categories of clinical presentations: arthritis 
and fever were the commonest symptoms occurring in 
82 patients (71.4%) followed by nonspecific febrile 
illness in 21 patients (18.2%); 12 patients (10.4%) 
presented with fever and variety of other uncommon 
presentations listed in Table 2. 
The most commonly involved joint with arthritis 
was the hip joint in 40 patients (40.8%) followed by 
the knee, ankle, elbow, sacroiliac, and wrist joints in 
39.7%, 10.7%, 4.3%, 3.2%, and 1.0% respectively. 
Monoarthritis was more common than polyarthritis: 
90% vs 10%. All patients who had arthritis recovered 
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fully without sequelae. Osteomyelitis was present in 
8.5% of patients. 
Routine laboratory findings are shown in Table 3. 
Leukocytosis (>lO,OOO lob/L) was seen in 22% of the 
115 patients tested, however, none of our patients had 
a white blood cell count of >20,000 lob/L. Leukopenia 
(~5000 lob/L) was seen in 9.5% of the 115 patients 
tested. Anemia (Hgb < 10 g/dL) was seen in 25% of the 
115 patients tested. The ESR was considered high (>25 
mm/h) in 73.8% of the 88 patients tested. Raised liver 
function tests was seen in 18.3% of the 49 patients 
tested. Among 89 blood cultures obtained, 40 (45%) 
were positive for brucella. Synovial fluids were less 
likely to be positive: three out of 15 (20%) cultured 
synovial fluids were positive. Only one patient had a 
positive CSF culture. This was a 2-year-old child who 
had Dandy-Walker disease (this includes obstruction 
of the outlet foramina of the fourth ventricle, which 
becomes massively dilated and hydrocephalus results 
from the obstruction of the CSF). A ventriculoperitoneal 
shunt was inserted early in life. This patient was 
admitted with fever and abdominal distention. CSF 
from the shunt tap and the ascitic fluid grew Brucellu 
species. The Brucella titer was 1:160 for B. abortus and 
1:320 for B. melitensis. The blood culture was negative. 
Among the 27 isolated brucella strains, 26 (96%) 
were B. melitensis and one (4%) was B. abortus. The 
SAT result is shown in Table 4: 90% had a titer > 1:640. 
In two patients, SAT was not done and one patient had 
a titer < 1:80. All these patients had positive blood 
cultures. Susceptibility tests were performed on 42 of 
44 isolates and the results are shown in Table 5. Only 
eight isolates (19%) were resistant to co-trimoxazole 
(trimethoprim/sulfamethoxazole (TMP/SMZ) and three 
isolates (7%) were resistant to rifampin. No strain was 
Table 5. Brucellosis in Children - 115 cases: Antimicrobial 
Susceptibility Data (Susceptibility Performed on 42744 Isolates 
(95%) 
Antimicrobial No. resistant Percent resistant 
Co-trimoxazole 8 19 
Rifampin 3 7 
Streptomycin 0 0 
Tetracycline 0 0 
No increase in resistance noted over the 1983-1995 study years. 
Table 6. Brucellosis in Children - 115 Cases: Treatment Regimens 
Regimen No. of patients 
Streptomycin+co-trimoxazole+rifampin 35 
Streptomycin+co-trimoxazole 27 
Rifampin+co-trimoxazole 15 
Streptomycin+tetracycline 14 
Streptomycin+tetracycline+co-trimoxazole 8 
Streptomycin+doxycycline+rifampin 6 
Other combinations 9 
No therapy 1 
Total 115 
resistant to tetracycline or streptomycin. There was no 
increase in the resistance noted over the years of the 
study. Various regimens of therapy were used as shown 
in Table 6. A combination of rifampin and co- 
trimoxazole with or without streptomycin was used in 
two thirds of the patients. The remaining one third 
received streptomycin plus tetracycline with or without 
rifampin or co-trimoxazole. Ninety eight patients had 
a complete therapy and follow up; 89 had complete 
recovery and eight (9%) relapsed after stopping therapy. 
One patient with neurobrucellosis died. Follow up was 
for >1 year for all patients. 
DISCUSSION 
Brucellosis is endemic in Saudi Arabia with a sero- 
prevalence of 15 %.2 Childhood brucellosis is common in 
our population. Among 545 cases that were reviewed 
over a 12-year period, 115 cases (21%) were children. In 
a seroprevalence study in Saudi Arabia carried out in 
1997, it was found that 9.7% of surveyed children ~15 
years of age were seropositive.2 Previous reports from 
the Kingdom showed a similar trend.1,4 The highest 
incidence was noticed during the years of 1987 and 1988 
at which time the disease was highly endemic in the 
kingdom. Brucellosis symptomatology is very variable, 
in part because of the variable pathogenecity of differ- 
ent strains. It is known that B. abortus causes milder 
disease with either mild symptomatology or focal 
lesions. However, infection with B. melitensis is usually 
associated with a high rate of bacteremia, short incu- 
bation periods, and noticeable symptoms. This was seen 
in our patients; 76% presented within two weeks of 
onset of their symptoms. This observation is in agree- 
ment with previous reports.rJ Arthralgiajarthritis and 
fever were the most common presenting combination of 
symptoms. Fever and arthritis were the most common 
presenting signs. Monoarthritis was more common than 
polyarthritis. This may create confusion with pyogenic 
arthritis in children; therefore in a community where 
brucella is common, awareness about this entity should 
prompt investigation for this disease, and physicians 
should have a high index of suspicion for brucella 
arthritis. The most commonly affected joints were hip 
and knee. Unlike in adults, the sacroiliac joint and axial 
skeleton were rarely affected. Brucella osteomyelitis is 
rare in children. Previous series showed that only l-2% 
of children with brucellosis have osteomyelitis; however, 
our study showed an 8% rate.1,5 This could be attributed 
to an increase in the use of radioisotopic imaging studies. 
Brucellosis can cause this disease in areas where it is 
endemic. Almost any organ can be affected and varied 
complications are being reported.‘@l’ In this series 
10.4% of the affected children had a febrile illness with 
uncommon presentations. Three children had neuro- 
brucellosis; one of them presented with abdominal 
distension. This child had a ventriculoperitoneal shunt 
and his neurobrucellosis manifested as peritonitis and 
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ascites. A similar presentation was reported in a lady 
who had a ventriculoperitoneal shunt inserted for in- 
creased intracranial pressure, which in retrospect was 
found to be due to brucellosis after brucella was isolated 
from ascitic fluid. Neurobrucellosis is rare in children 
and it has been reported in only 0.5-l % of children with 
brucellosis.12-r4 Most of the affected children present 
with acute meningitis or meningoencephalitis. Recovery 
is usual and sequelae are rare. Hematological abnor- 
malities are not uncommon in brucellosis. In our series 
25 % of patients tested had anemia. Similar findings have 
been reported by others. is Leukocytosis was seen in up 
to 25% of our patients. Lymphocytosis is prominent in 
the differential count, occurring in 70%. Other studies 
have shown variable results with some reporting 
lymphopenia and some reporting lymphocytosis.‘*” 
Thrombocytopenia is seen less frequently and is usually 
mild; however, severe thrombocytopenia has been 
reported. *i Two of our patients had severe thrombo- 
cytopenia (<50,000), which recovered after 10 days of 
initiating antibrucella therapy. Several mechanisms have 
been entertained for these hematological abnormalities. 
These include bone marrow suppression, peripheral 
destruction, hemophagocytosis, as well as immune 
mechanisms. 
Although positive culture should be the gold 
standard for diagnosis, its yield remains suboptimal. 
Most studies have shown a 40-50% yield. Culture in 
biphasic medium (Castaneda method) and lysis concen- 
tration have been recommended to improve the recovery 
of brucella.18 Rapid diagnosis of brucella using the auto- 
mated system of nonradiometric BACTEC or BACT/ 
ALERT has shown a better and faster recovery.7,‘9 
Because of the lower yield of culture, SAT remains the 
best diagnostic modality available. In endemic areas 
there may be a persistent and continuing exposure to 
the source of infection, and therefore there may be a 
persistent low titer in the range of 1:160-1:320 in the 
absence of true infection.” In these areas a titer of 1:640 
or higher is a good predictor of the presence of the 
disease. Our study showed that 92% of children with 
acute brucellosis have a titer of 1:640 or more. Coupling 
SAT with the 2-mercaptoethanol agglutination test is 
useful in differentiating acute from chronic brucellosis. 
The 2-mercaptoethanol agglutination test elutes IgM 
out leaving IgG. Elevated IgG titers indicate an acute 
disease. A negative 2-mercaptoethanol test after therapy 
indicates a good response to treatment. False negative 
SAT results also occur but are rare, as is shown in this 
study where only one patient had negative serology and 
positive blood culture. ELISA is a promising serological 
test and has shown to be of better sensitivity and 
specificity.20 
The armamentarium of antibiotics for treating 
childhood brucellosis is limited. Available proven 
effective antibiotics include aminoglycosides, rifampin, 
and trimethoprim/sulfamethoxazole (TMP/SMX). Tetra- 
cyclines can be used for those who are >8 years of age. 
The most effective regimen includes a combination 
therapy given for four to six weeks.1,21 Such combina- 
tions are usually TMP/SMX and rifampin, with or 
without streptomycin for two weeks or gentamicin 
for five days. Doxycycline can replace rifampin or TMP/ 
SMX for children >8 years of age. Short duration 
therapies of <4 weeks have proven to be less 
effective.1.22 However, one study showed that three 
weeks’ duration therapy is as effective as five weeks and 
eight weeks of therapy. 23 In this study the standard of 
four weeks combination therapy was adopted, and only 
a 9% relapse rate was observed. In our population it is 
difficult to differentiate between relapse and reinfection 
as some of our patients continued to be exposed to the 
source of infection. Therefore this 9% relapse may be 
overestimated. The eradication of human brucellosis 
ultimately depends on the eradication of animal 
brucellosis. Although education of the public has been 
advocated as an alternative strategy to control disease in 
humans, it should be considered as an adjunct and not 
an alternative.24 
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